FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Bio-pharm Ranitidine Syrup Recall

Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottl…

Bio-pharm, Inc. · Levittown, PA

Risk level
Class III
Reported by FDA
Apr 13, 2016
Recall ID
D-0809-2016
Check your lot numberHow we source this data

Summary

Bio-pharm recalled Ranitidine Syrup starting Dec 17, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0809-2016 on Apr 13, 2016. Reason: Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.

Product description

Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, Mfd For: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724, NDC 23155-291-51

Lot numbers, UPCs & expiration codes

Lot #s: 14G008, 14G013, 14G010, 14G015, 14G016, 14G021, 14G026, 14G028, Exp. 01/2016; 14K027, 14K023, Exp. 04/2016; 15B040, 15B041, Exp. 08/2016; 15E042, Exp. 11/2016; 15F019, 15F021, Exp. 12/2016; 15G038, Exp. 01/2017; 15H004, 15H008, Exp. 02/2017

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0809-2016
Classification
Class III
Status
Terminated
Recall initiated
Dec 17, 2015
FDA report date
Apr 13, 2016
Quantity
103,664 Bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Bio-pharm, Inc.

Original FDA data

Every field from FDA enforcement report D-0809-2016, exactly as published.

Show all FDA fields
City
Levittown
State
PA
Status
Terminated
Country
United States
Event ID
72819
Address
2091 Hartel Ave
Code information
Lot #s: 14G008, 14G013, 14G010, 14G015, 14G016, 14G021, 14G026, 14G028, Exp. 01/2016; 14K027, 14K023, Exp. 04/2016; 15B040, 15B041, Exp. 08/2016; 15E042, Exp. 11/2016; 15F019, 15F021, Exp. 12/2016; 15G038, Exp. 01/2017; 15H004, 15H008, Exp. 02/2017
Postal code
19057-4506
Report date
Apr 13, 2016
Product type
Drugs
Recall number
D-0809-2016
Classification
Class III
Recalling firm
Bio-pharm, Inc.
Product quantity
103,664 Bottles
Termination date
May 8, 2017
Reason for recall
Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL (75 mg/5 mL), 16 fl oz Bottle, Rx only, Mfd For: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724, NDC 23155-291-51
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Dec 17, 2015
Initial firm notification
Letter
Center classification date
Apr 1, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0809-2016, published Apr 13, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls